AusPAR: Capecitabine / Oxaliplatin
Related information
- Australian Public Assessment Reports for prescription medicines (AusPARs)
- Browse AusPARs by active ingredient
- Browse AusPARs by product name
- Browse AusPARs by sponsor
How to access a pdf or Word document
*Large file warning: Attempting to open large files over the Internet within the browser window may cause problems. It is strongly recommended you download this document to your own computer and open from there.
Australian Public Assessment Report
30 March 2011
| AusPAR | |
|---|---|
| Active Ingredient | Capecitabine / Oxaliplatin
|
| Product Name | Xeloda / Eloxatin / Oxaliplatin Dakota / Winthrop Oxaliplatin
|
| Sponsor | Roche Products Pty Ltd / Sanofi-Aventis Australia Pty Ltd
|
| Submission Number | PM-2010-00909-4/ 2010-02795-4
|
| Submission Type | Major variation (extension of indications, new dosage)
|
| AusPAR Date | 23 March 2011
|
| Publication Date | 30 March 2011 |